Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
80
GTLB Quote, Financials, Valuation and Earnings
Last price:
$43.92
Seasonality move
:
-6.63%
Day range:
$42.68 - $43.93
52-week range:
$37.90 - $74.18
Dividend yield:
0%
P/E ratio:
439.20x
P/S ratio:
9.03x
P/B ratio:
8.98x
Volume:
3M
Avg. volume:
5.5M
1-year change:
-20.71%
Market cap:
$7.3B
Revenue:
$759.2M
EPS (TTM):
$0.10
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $152.2M | $252.7M | $424.3M | $579.9M | $759.2M | |
| Revenue Growth (YoY) | 87.35% | 66.03% | 67.95% | 36.66% | 30.93% | |
| Cost of Revenues | $18.5M | $30M | $51.7M | $59.7M | $85.1M | |
| Gross Profit | $133.7M | $222.7M | $372.7M | $520.2M | $674.1M | |
| Gross Profit Margin | 87.87% | 88.13% | 87.82% | 89.7% | 88.79% | |
| R&D Expenses | $106.6M | $97.2M | $156.1M | $200.8M | $239.7M | |
| Selling, General & Admin | $241M | $254.4M | $427.9M | $506.8M | $577.2M | |
| Other Inc / (Exp) | $23.5M | -$30.9M | $21.6M | -$12.2M | $9.2M | |
| Operating Expenses | $347.6M | $351.6M | $584.1M | $707.6M | $816.8M | |
| Operating Income | -$213.9M | -$129M | -$211.4M | -$187.4M | -$142.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$189.4M | -$159.1M | -$175.3M | -$160.6M | -$85.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.8M | -$1.5M | $4M | $265.1M | -$76.7M | |
| Net Income to Company | -$192.2M | -$157.6M | -$181.8M | -$429.5M | -$9.1M | |
| Minority Interest in Earnings | -- | $2.4M | $8.4M | $3.9M | $2.8M | |
| Net Income to Common Excl Extra Items | -$192.2M | -$155.1M | -$173.4M | -$425.7M | -$6.3M | |
| Basic EPS (Cont. Ops) | -$1.45 | -$1.95 | -$1.17 | -$2.76 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -$1.45 | -$1.95 | -$1.17 | -$2.76 | -$0.04 | |
| Weighted Average Basic Share | $132.5M | $79.8M | $148.4M | $154.3M | $160.6M | |
| Weighted Average Diluted Share | $132.5M | $79.8M | $148.4M | $154.3M | $160.6M | |
| EBITDA | -$213.7M | -$127.7M | -$205.8M | -$180.9M | -$131.7M | |
| EBIT | -$213.9M | -$129M | -$211.4M | -$187.4M | -$142.7M | |
| Revenue (Reported) | $152.2M | $252.7M | $424.3M | $579.9M | $759.2M | |
| Operating Income (Reported) | -$213.9M | -$129M | -$211.4M | -$187.4M | -$142.7M | |
| Operating Income (Adjusted) | -$213.9M | -$129M | -$211.4M | -$187.4M | -$142.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $49.9M | $87.4M | $126.9M | $169.2M | $214.5M | |
| Revenue Growth (YoY) | 69.17% | 75.06% | 45.16% | 33.35% | 26.79% | |
| Cost of Revenues | $6.4M | $9.8M | $13.9M | $18.8M | $25M | |
| Gross Profit | $43.5M | $77.6M | $112.9M | $150.4M | $189.5M | |
| Gross Profit Margin | 87.13% | 88.73% | 89.01% | 88.9% | 88.33% | |
| R&D Expenses | $21.3M | $31.8M | $50.4M | $54.1M | $65.4M | |
| Selling, General & Admin | $48.2M | $88.6M | $120.8M | $149.9M | $158.7M | |
| Other Inc / (Exp) | -$1.1M | $18.4M | $253K | -$889K | -$10M | |
| Operating Expenses | $69.5M | $120.4M | $171.2M | $204.1M | $224.1M | |
| Operating Income | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$27M | -$23.9M | -$50.7M | -$42.5M | -$33.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3M | $2.5M | $1.5M | $13M | $2.5M | |
| Net Income to Company | -$28.3M | -$26.6M | -$52.9M | -$55.5M | -$36.3M | |
| Minority Interest in Earnings | $345K | $514K | $430K | $243K | $383K | |
| Net Income to Common Excl Extra Items | -$27.9M | -$26.1M | -$52.5M | -$55.2M | -$35.9M | |
| Basic EPS (Cont. Ops) | -$0.21 | -$0.18 | -$0.35 | -$0.35 | -$0.22 | |
| Diluted EPS (Cont. Ops) | -$0.21 | -$0.18 | -$0.35 | -$0.35 | -$0.22 | |
| Weighted Average Basic Share | $132.5M | $146.6M | $151.7M | $158.2M | $164.5M | |
| Weighted Average Diluted Share | $132.5M | $146.6M | $151.7M | $158.2M | $164.5M | |
| EBITDA | -$25.9M | -$41.7M | -$56.6M | -$51.6M | -$32M | |
| EBIT | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Revenue (Reported) | $49.9M | $87.4M | $126.9M | $169.2M | $214.5M | |
| Operating Income (Reported) | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Operating Income (Adjusted) | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $172.6M | $290.1M | $463.8M | $622.2M | $804.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $21.1M | $33.4M | $55.8M | $64.5M | $91.4M | |
| Gross Profit | $151.5M | $256.7M | $408M | $557.7M | $713.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $108.9M | $107.7M | $174.7M | $204.6M | $250.9M | |
| Selling, General & Admin | $250.4M | $294.8M | $460.1M | $535.9M | $585.9M | |
| Other Inc / (Exp) | $24.9M | -$11.4M | $3.4M | -$13.4M | -$217K | |
| Operating Expenses | $359.3M | $402.5M | $634.8M | $740.5M | $836.9M | |
| Operating Income | -$207.8M | -$145.8M | -$226.8M | -$182.8M | -$123.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$182.6M | -$155.9M | -$202.1M | -$152.4M | -$77.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | -$256K | $3M | $276.6M | -$86.8M | |
| Net Income to Company | -- | -$155.9M | -$208.1M | -$432.1M | $10.1M | |
| Minority Interest in Earnings | $345K | $2.6M | $8.3M | $3.7M | $2.9M | |
| Net Income to Common Excl Extra Items | -$186M | -$153.3M | -$199.8M | -$428.4M | $12.4M | |
| Basic EPS (Cont. Ops) | -$1.40 | -$1.40 | -$1.34 | -$2.75 | $0.11 | |
| Diluted EPS (Cont. Ops) | -$1.40 | -$1.40 | -$1.34 | -$2.75 | $0.10 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$207.6M | -$143.5M | -$220.6M | -$176M | -$112.1M | |
| EBIT | -$207.8M | -$145.8M | -$226.8M | -$182.8M | -$123.7M | |
| Revenue (Reported) | $172.6M | $290.1M | $463.8M | $622.2M | $804.6M | |
| Operating Income (Reported) | -$207.8M | -$145.8M | -$226.8M | -$182.8M | -$123.7M | |
| Operating Income (Adjusted) | -$207.8M | -$145.8M | -$226.8M | -$182.8M | -$123.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $49.9M | $87.4M | $126.9M | $169.2M | $214.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.4M | $9.8M | $13.9M | $18.8M | $25M | |
| Gross Profit | $43.5M | $77.6M | $112.9M | $150.4M | $189.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $21.3M | $31.8M | $50.4M | $54.1M | $65.4M | |
| Selling, General & Admin | $48.2M | $88.6M | $120.8M | $149.9M | $158.7M | |
| Other Inc / (Exp) | -$1.1M | $18.4M | $253K | -$889K | -$10M | |
| Operating Expenses | $69.5M | $120.4M | $171.2M | $204.1M | $224.1M | |
| Operating Income | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$27M | -$23.9M | -$50.7M | -$42.5M | -$33.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3M | $2.5M | $1.5M | $13M | $2.5M | |
| Net Income to Company | -$28.3M | -$26.6M | -$52.9M | -$55.5M | -$36.3M | |
| Minority Interest in Earnings | $345K | $514K | $430K | $243K | $383K | |
| Net Income to Common Excl Extra Items | -$27.9M | -$26.1M | -$52.5M | -$55.2M | -$35.9M | |
| Basic EPS (Cont. Ops) | -$0.21 | -$0.18 | -$0.35 | -$0.35 | -$0.22 | |
| Diluted EPS (Cont. Ops) | -$0.21 | -$0.18 | -$0.35 | -$0.35 | -$0.22 | |
| Weighted Average Basic Share | $132.5M | $146.6M | $151.7M | $158.2M | $164.5M | |
| Weighted Average Diluted Share | $132.5M | $146.6M | $151.7M | $158.2M | $164.5M | |
| EBITDA | -$25.9M | -$41.7M | -$56.6M | -$51.6M | -$32M | |
| EBIT | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Revenue (Reported) | $49.9M | $87.4M | $126.9M | $169.2M | $214.5M | |
| Operating Income (Reported) | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Operating Income (Adjusted) | -$26M | -$42.9M | -$58.2M | -$53.6M | -$34.6M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $282.9M | $884.7M | $295.4M | $288M | $227.6M | |
| Short Term Investments | -- | $50M | $641.2M | $748.3M | $764.7M | |
| Accounts Receivable, Net | $39.7M | $77.2M | $130.5M | $166.7M | $264.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $6.8M | $15.2M | $16.2M | $36.5M | $25.1M | |
| Other Current Assets | $500K | $265K | $1.7M | $954K | $1.3M | |
| Total Current Assets | $348.5M | $1.1B | $1.1B | $1.3B | $1.3B | |
| Property Plant And Equipment | -- | $3.3M | $6.8M | $3.4M | $4.4M | |
| Long-Term Investments | -- | -- | $12.7M | -- | -- | |
| Goodwill | -- | $8.1M | $8.1M | $8.1M | $16.1M | |
| Other Intangibles | $797K | $6.3M | $3.9M | $1.7M | $17.8M | |
| Other Long-Term Assets | -- | $3.4M | $321K | $559K | $370K | |
| Total Assets | $362.6M | $1.1B | $1.2B | $1.3B | $1.4B | |
| Accounts Payable | $3.1M | $5M | $5.2M | $1.7M | $7.5M | |
| Accrued Expenses | $4M | $11.6M | $19.5M | $24.4M | $29.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $716K | $410K | $275K | |
| Other Current Liabilities | $1.2M | -- | $2.5M | $3.6M | -- | |
| Total Current Liabilities | $127.2M | $241.6M | $306.3M | $677.2M | $545M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $593.8M | $292.2M | $344.5M | $715M | $578M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -$19.9M | $7.7M | -$705K | $2.4M | -$8.5M | |
| Common Equity | -$231.2M | $774.9M | $771M | $559.8M | $775.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $24.4M | $53.7M | $46.6M | $45.4M | |
| Total Equity | -$231.2M | $799.3M | $824.7M | $606.4M | $821.3M | |
| Total Liabilities and Equity | $362.6M | $1.1B | $1.2B | $1.3B | $1.4B | |
| Cash and Short Terms | $282.9M | $934.7M | $936.7M | $1B | $992.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $887.5M | $315.9M | $420.3M | $255.7M | |
| Short Term Investments | -- | $47.3M | $621.7M | $641.2M | $849.1M | |
| Accounts Receivable, Net | -- | $68M | $126.1M | $135.2M | $201.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $16.6M | $17.1M | -- | -- | |
| Other Current Assets | -- | $970K | $2.1M | $35.3M | $39.1M | |
| Total Current Assets | -- | $1B | $1.1B | $1.3B | $1.4B | |
| Property Plant And Equipment | -- | $4.3M | $6.2M | $3.4M | $5.2M | |
| Long-Term Investments | -- | $15.6M | $11.7M | -- | -- | |
| Goodwill | -- | $8.1M | $8.1M | $16.1M | $16M | |
| Other Intangibles | -- | $5.7M | $3.3M | $16.6M | $15.8M | |
| Other Long-Term Assets | -- | $3.6M | $672K | $4.8M | $4.4M | |
| Total Assets | -- | $1.1B | $1.2B | $1.3B | $1.4B | |
| Accounts Payable | -- | $5.7M | $3M | $3.2M | $11.3M | |
| Accrued Expenses | -- | $12.3M | $14.5M | $24.8M | $66.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $911K | $371K | -- | |
| Other Current Liabilities | -- | $4.2M | -- | -- | -- | |
| Total Current Liabilities | -- | $234.6M | $311.1M | $674.5M | $556.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $280.8M | $348.5M | $707.3M | $589.4M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | $6.3M | $1M | $3.4M | -$1.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $36.1M | $50.1M | $46.5M | $44.3M | |
| Total Equity | -- | $818.2M | $815.6M | $614.4M | $852.6M | |
| Total Liabilities and Equity | -- | $1.1B | $1.2B | $1.3B | $1.4B | |
| Cash and Short Terms | -- | $934.8M | $937.6M | $1.1B | $1.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$192.2M | -$157.6M | -$181.8M | -$429.5M | -$9.1M | |
| Depreciation & Amoritzation | $222K | $1.2M | $5.6M | $6.5M | $11M | |
| Stock-Based Compensation | $111.8M | $30M | $122.6M | $163M | $185.9M | |
| Change in Accounts Receivable | -$14.7M | -$38.2M | -$54.2M | -$36.3M | -$99.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$73.6M | -$49.8M | -$77.4M | $35M | -$64M | |
| Capital Expenditures | -- | $3.5M | $6.1M | $1.6M | $3.8M | |
| Cash Acquisitions | -- | -$323K | -$9.6M | -- | -$20.2M | |
| Cash From Investing | -$842K | -$53.9M | -$605.7M | -$86.2M | -$30.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$820K | -$590K | -- | -- | -- | |
| Other Financing Activities | -- | $21.8M | $58.6M | -- | -$4.9M | |
| Cash From Financing | $12.9M | $701.2M | $97.5M | $45.2M | $32.6M | |
| Beginning Cash (CF) | $343.3M | $282.9M | $887.2M | $297.9M | $288M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$61.5M | $597.5M | -$585.6M | -$6M | -$61.8M | |
| Ending Cash (CF) | $282.9M | $887.2M | $297.9M | $288M | $227.6M | |
| Levered Free Cash Flow | -$73.6M | -$53.4M | -$83.5M | $33.4M | -$67.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$28.3M | -$26.6M | -$52.9M | -$55.5M | -$36.3M | |
| Depreciation & Amoritzation | $84K | $1.1M | $1.7M | $2M | $2.6M | |
| Stock-Based Compensation | $3.4M | $17.5M | $32.3M | $42.3M | $55.8M | |
| Change in Accounts Receivable | $4.1M | $8.7M | $4.8M | $31.1M | $65.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$21.5M | -$28.2M | -$11M | $38.1M | $106.3M | |
| Capital Expenditures | -- | $1.9M | $256K | $700K | $912K | |
| Cash Acquisitions | -- | -$9.6M | -- | -$20.2M | -- | |
| Cash From Investing | -- | -$8.8M | $24.4M | $89.4M | -$81.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $2.9M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$590K | -- | -- | -- | -- | |
| Other Financing Activities | $7.5M | $35.5M | -- | -- | -- | |
| Cash From Financing | $11M | $43.7M | $7.5M | $5.1M | $3.3M | |
| Beginning Cash (CF) | $282.9M | $887.2M | $297.9M | $288M | $227.6M | |
| Foreign Exchange Rate Adjustment | -$130K | -$3.9M | -$401K | -$290K | $331K | |
| Additions / Reductions | -$10.5M | $6.7M | $20.9M | $132.6M | $27.7M | |
| Ending Cash (CF) | $272.2M | $890M | $318.4M | $420.3M | $255.7M | |
| Levered Free Cash Flow | -$21.5M | -$30M | -$11.2M | $37.4M | $105.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$155.9M | -$208.1M | -$432.1M | $10.1M | |
| Depreciation & Amoritzation | -- | $2.3M | $6.1M | $6.9M | $11.5M | |
| Stock-Based Compensation | $3.4M | $44M | $137.4M | $173M | $199.5M | |
| Change in Accounts Receivable | -- | -$33.6M | -$58M | -$10.1M | -$64.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$56.4M | -$60.2M | $84.1M | $4.2M | |
| Capital Expenditures | -- | $1.9M | $4.5M | $2M | $4M | |
| Cash Acquisitions | -- | -$9.9M | -- | -$20.2M | -- | |
| Cash From Investing | -- | -$62.7M | -$572.5M | -$21.2M | -$201.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $49.8M | -- | -- | -- | |
| Cash From Financing | -- | $733.9M | $61.3M | $42.8M | $30.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $614.7M | -$571.4M | $105.7M | -$166.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$56.4M | -$64.7M | $82.1M | $216K | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$28.3M | -$26.6M | -$52.9M | -$55.5M | -$36.3M | |
| Depreciation & Amoritzation | $84K | $1.1M | $1.7M | $2M | $2.6M | |
| Stock-Based Compensation | $3.4M | $17.5M | $32.3M | $42.3M | $55.8M | |
| Change in Accounts Receivable | $4.1M | $8.7M | $4.8M | $31.1M | $65.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$21.5M | -$28.2M | -$11M | $38.1M | $106.3M | |
| Capital Expenditures | -- | $1.9M | $256K | $700K | $912K | |
| Cash Acquisitions | -- | -$9.6M | -- | -$20.2M | -- | |
| Cash From Investing | -- | -$8.8M | $24.4M | $89.4M | -$81.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $2.9M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$590K | -- | -- | -- | -- | |
| Other Financing Activities | $7.5M | $35.5M | -- | -- | -- | |
| Cash From Financing | $11M | $43.7M | $7.5M | $5.1M | $3.3M | |
| Beginning Cash (CF) | $282.9M | $887.2M | $297.9M | $288M | $227.6M | |
| Foreign Exchange Rate Adjustment | -$130K | -$3.9M | -$401K | -$290K | $331K | |
| Additions / Reductions | -$10.5M | $6.7M | $20.9M | $132.6M | $27.7M | |
| Ending Cash (CF) | $272.2M | $890M | $318.4M | $420.3M | $255.7M | |
| Levered Free Cash Flow | -$21.5M | -$30M | -$11.2M | $37.4M | $105.4M | |
Get GTLB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GTLB
Sector
P/E ratio
439.20x
23.75x
PEG ratio
-0.24x
0.00x
P/B ratio
8.98x
2.35x
Price / LTM sales
9.03x
1.66x
Growth Metrics
GTLB
Sector
Revenue growth
26.79%
3.91%
Earnings growth
--
11.1%
Revenue (5-year growth)
56.36%
6.27%
Earnings forecast
$0.15
$0.12
Profitability
GTLB
Sector
Profitability FY 2024
$674.1M
$76.5M
Return on invested capital
1.66%
0.05%
Return on assets
0.92%
-0.48%
Return on equity
1.66%
0.73%
Earnings Date
Last Earnings Date
Jun
10
Next Earnings Date
Sep
3
Estimated Next Earnings Date
Sep
9
Balance Sheet
GTLB
Sector
Total cash
$1.1B
$48.7M
Short term investments
$764.7M
$19.4M
Total assets
$1.4B
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
